Podcasts about sao paulo

Continúan los megaoperativos en Brasil para combatir el crimen organizado. Este jueves fue en Sao Paulo contra el lavado de dinero del “Primeiro Comando da Capital”, la mafia más grande del país. Las cifras del operativo, que terminó con cuatro personas detenidas y otra murió, no se comparan con las del pasado martes en Río de Janeiro que dejó cerca de 121 fallecidos. El objetivo es el mismo, combatir el crimen organizado, pero el método de las autoridades brasileñas cambia según el lugar: mientras más pobre es la zona la policía interviene con más violencia, alerta Paulo Cesar Carbonari, miembro del Movimiento Nacional de Derechos Humanos de Brasil. Para él, el operativo en Rio de Janeiro del martes y el del jueves en la ciudad de Campinas, Estado de Sao Paulo, son una clara muestra de esta desigualdad.   “En los dos casos son muy, muy ilustrativos y muy importantes, porque en San Paulo es una operación que se hizo en una región donde no están los pobres, donde están los más ricos del país. En Río la operación de estos días fue en dos de las mayores favelas de la ciudad, donde están millones de personas trabajadoras, pobres, mujeres, jóvenes, sobre todo negras y negros. La situación es muy clara, o sea, no se combate el crimen organizado atacando las poblaciones, las favelas, porque ahí no están los que manejan el dinero del crimen organizado. Por eso cuando ocurre lo que ocurrió en Río de Janeiro, no están combatiendo el crimen organizado, están combatiendo a la población”, se interroga Carbonari. El balance oficial del operativo en Río de Janeiro es de 121 muertos y 113 detenidos, lo que la convirtió en la operación más mortal de la historia de Brasil. Las familias acudieron a reconocer los cuerpos acomodados a lo largo de una calle. Carbonari alerta que operaciones como la de Río de Janeiro no debería existir. “Hay una decisión del Tribunal Superior Constitucional de Brasil para que se hagan operaciones en las favelas. El Gobierno de Río no respetó ni las reglas elementales, ni la decisión judicial del Tribunal Superior sobre lo que debía hacer, por lo tanto, exigir una investigación justa es necesario para que no se quede en impunidad, agregó”. El operativo de Campinas buscaba cumplir nueve órdenes de detención y once de allanamientos. Uno de los cuatro detenidos era un influencer llamado Eduardo Magrini, que presume un Rolex, regalo de un artista, y que la Fiscalía lo identifica como un miembro importante del Primeiro Comando da Capital. “No es que la policía de Sao Paulo sea mejor que la de Río de Janeiro”, indica Carboneri, quien asegura que las autoridades entran de forma más violenta en comunidades vulnerables, “pero no tan violenta, o sea con otras formas y otras estrategias en -lugares- donde no están los pobres”, aseveró. Cesar Carbonari resaltó que en Brasil falta una estrategia nacional contra el crimen organizado porque son los gobiernos locales los que ordenan los operativos como los dos de esta semana.

Continúan los megaoperativos en Brasil para combatir el crimen organizado. Este jueves fue en Sao Paulo contra el lavado de dinero del “Primeiro Comando da Capital”, la mafia más grande del país. Las cifras del operativo, que terminó con cuatro personas detenidas y otra murió, no se comparan con las del pasado martes en Río de Janeiro que dejó cerca de 121 fallecidos. El objetivo es el mismo, combatir el crimen organizado, pero el método de las autoridades brasileñas cambia según el lugar: mientras más pobre es la zona la policía interviene con más violencia, alerta Paulo Cesar Carbonari, miembro del Movimiento Nacional de Derechos Humanos de Brasil. Para él, el operativo en Rio de Janeiro del martes y el del jueves en la ciudad de Campinas, Estado de Sao Paulo, son una clara muestra de esta desigualdad.   “En los dos casos son muy, muy ilustrativos y muy importantes, porque en San Paulo es una operación que se hizo en una región donde no están los pobres, donde están los más ricos del país. En Río la operación de estos días fue en dos de las mayores favelas de la ciudad, donde están millones de personas trabajadoras, pobres, mujeres, jóvenes, sobre todo negras y negros. La situación es muy clara, o sea, no se combate el crimen organizado atacando las poblaciones, las favelas, porque ahí no están los que manejan el dinero del crimen organizado. Por eso cuando ocurre lo que ocurrió en Río de Janeiro, no están combatiendo el crimen organizado, están combatiendo a la población”, se interroga Carbonari. El balance oficial del operativo en Río de Janeiro es de 121 muertos y 113 detenidos, lo que la convirtió en la operación más mortal de la historia de Brasil. Las familias acudieron a reconocer los cuerpos acomodados a lo largo de una calle. Carbonari alerta que operaciones como la de Río de Janeiro no debería existir. “Hay una decisión del Tribunal Superior Constitucional de Brasil para que se hagan operaciones en las favelas. El Gobierno de Río no respetó ni las reglas elementales, ni la decisión judicial del Tribunal Superior sobre lo que debía hacer, por lo tanto, exigir una investigación justa es necesario para que no se quede en impunidad, agregó”. El operativo de Campinas buscaba cumplir nueve órdenes de detención y once de allanamientos. Uno de los cuatro detenidos era un influencer llamado Eduardo Magrini, que presume un Rolex, regalo de un artista, y que la Fiscalía lo identifica como un miembro importante del Primeiro Comando da Capital. “No es que la policía de Sao Paulo sea mejor que la de Río de Janeiro”, indica Carboneri, quien asegura que las autoridades entran de forma más violenta en comunidades vulnerables, “pero no tan violenta, o sea con otras formas y otras estrategias en -lugares- donde no están los pobres”, aseveró. Cesar Carbonari resaltó que en Brasil falta una estrategia nacional contra el crimen organizado porque son los gobiernos locales los que ordenan los operativos como los dos de esta semana.

Les habitants du nord des Caraïbes se réveillent dans les décombres du passage de l'ouragan Melissa. Le nombre de victimes ne cesse d'augmenter. L'ouragan Melissa se dirige désormais vers les Bermudes qu'il devrait atteindre ce soir (30 octobre 2025). L'ouragan a déjà dévasté plusieurs îles des Caraïbes. Haïti paye le plus lourd tribut. En Haïti, le dernier bilan est de 24 morts, 18 disparus et de nombreux blessés, rapporte Le Nouvelliste. Le bilan peut encore évoluer, affirme Frantz Duval, rédacteur en chef du Nouvelliste sur notre antenne. «Le gouvernement semble pris de court, affirme-t-il. On n'a pas encore annoncé de mesures concrètes. Ils sont comme le reste de la population, ils ne savent pas vraiment ce qu'il s'est passé dans les villes de province».   Cuba, entre ouragan et blocus Cuba est donc le dernier pays touché par Melissa. Les inondations sont le principal problème pour l'île, estime le site 14 y medio. Des torrents d'eau emportant tout sur leur passage. Les pluies abondantes ont continué même après le passage de Melissa. Le fournisseur d'électricité national a annoncé qu'une grande partie de la population se trouvait sans électricité, mais aussi sans réseau téléphonique. Le pays traverse une grave crise économique et certains habitants des zones sinistrées se sentent abandonnés. «Avant l'arrivée de l'ouragan, les autorités sont venues nous dire de trouver nous-mêmes un endroit où nous mettre à l'abri parce que le gouvernement n'avait pas de lieux où nous évacuer», témoigne Elsa Listy Isacc Reyes jointe par RFI. Cette mère d'un adolescent de 17 ans vit à 40 km de Santiago de Cuba. Sa maison a été détruite. «Moi, je suis allée me réfugier chez ma voisine, ajoute-t-elle. Je n'ai pas reçu d'aide pour l'instant : ni du gouvernement, ni de personne. Je n'ai pas de proches vers qui me tourner. Ma famille et moi, on est vraiment, vraiment désespérés.»   Au Brésil, la polémique grandit après l'opération policière à Rio Au Brésil, la population et les autorités tentent encore de comprendre ce qui a transformé une intervention policière contre le crime organisé en bain de sang mardi (28 octobre 2025) dans des favelas de Rio. Le bilan provisoire officiel est de 119 morts dont quatre policiers. C'est l'opération policière la plus meurtrière de l'histoire dans le pays. Pour l'heure, l'identité des morts n'a toujours pas été révélée, mise à part celle de policiers. On ne sait donc pas s'ils étaient visés par le mandat judiciaire de cette opération. Certains habitants dénoncent des exécutions et un juge de la Cour suprême brésilienne a convoqué une audience lundi prochain (3 novembre 2025) pour que le gouverneur de l'État de Rio, Claudio Castro, commanditaire de l'opération fournisse des détails. Mais dans la presse, le débat a déjà commencé. Dans un éditorial de la Folha de Sao Paulo, le journaliste Vinicius Torres Freire accuse la droite d'avoir simplement voulu relancer sa campagne par le sang. Claudio Castro est, en effet, un allié de l'ancien président Bolsonaro. «La droite était acculée, sur la défensive», développe l'éditorialiste. «Les gouverneurs de droite «expriment aujourd'hui leur solidarité» à Claudio Castro — ils tentent de diffuser l'idée que Castro et la sécurité de Rio sont abandonnés par le pouvoir fédéral, par le président Lula notamment.» La Folha précise également que «la gauche n'a jamais été capable de présenter un plan de sécurité, laissant le champ libre à une nouvelle invasion barbare des démagogues de la mort.» Le média O Globo, de son côté, a interviewé l'ancien secrétaire national de la Sécurité publique. Ricardo Balestreri reconnait que le crime organisé exerce «un pouvoir tyrannique sur une large partie du territoire de Rio» mais «aucun criminel important n'habite dans une favela», affirme-t-il. Autrement dit, combattre le crime organisé uniquement dans les quartiers les plus pauvres revient à tromper la population.   Chili : Jeannette Jara, candidate de la gauche à la présidentielle Dans deux semaines (dimanche 16 novembre), le Chili se rendra aux urnes pour le premier tour d'une élection présidentielle très polarisée. Les deux candidats qui sont, pour le moment, en tête dans les sondages sont à l'opposé l'un de l'autre. D'un côté, José Antonio Kast à l'extrême droite, face à lui Jeannette Jara, communiste et candidate de la gauche réunie. Il ne leur reste plus que quelques jours pour faire campagne et tenter d'élargir leur base électorale. Jeannette Jara qui a créé un certain engouement surtout chez les femmes. Elle qui est issue d'une famille pauvre et a gravi les échelons un à un, jusqu'à devenir ministre du Travail dans l'actuel gouvernement du président Gabriel Boric. Écoutez le reportage de notre correspondante Naïla Derroisné à Santiago.

Professeur de Sciences politiques à l'Université américaine de Paris, Philip Golub analyse pour RFI la politique étrangère de Donald Trump, qui poursuit cette semaine sa tournée en Asie. «America first», l'expression est née dans les années 1920 aux États-Unis, dans la bouche de ceux qui étaient en désaccord avec les engagements internationaux du président de l'époque, puis remise au goût du jour par Donald Trump près d'un siècle après. Il la martèle depuis son retour à la Maison Blanche. Pourtant, Donald Trump est présent sur un maximum de fronts ces derniers mois. Alors comment qualifier la politique étrangère de Donald Trump ?  «Les États-Unis sont structurellement une puissance globalisée, nuance Philip Golub. Donald Trump n'est pas un isolationniste, mais un unilatéraliste, qui veut imposer sa volonté dans différents théâtres du monde, selon ce qu'il estime être l'intérêt national des États-Unis, poursuit celui qui enseigne à l'Université américaine de Paris (AUP). Ce qui correspond d'assez près à son intérêt personnel». Il va plus loin : «La politique internationale de Donald Trump est dirigée par son ego».    Après la Jamaïque, l'ouragan Melissa touche Cuba et fait au moins 10 morts en Haïti Le jour d'après en Jamaïque. L'ouragan Melissa a traversé l'île des Caraïbes, mardi 28 octobre 2025, laissant de lourds dégâts sur son passage. Un «Désastre !» pour The Jamaica Observer. En Une du journal, s'affiche un amas de tôles et de poutres en partie immergées dans une eau boueuse. The Gleaner, pour sa part, multiplie les adjectifs choc : «Défiguré(e)», écrit le journal en majuscules, à sa Une ce mercredi 29 octobre 2025. «Ravagé(e)», lit-on aussi en titre d'un article sur son site. Le quotidien décrit les arbres arrachés, les lignes téléphoniques à terre.  Melissa a atteint, mercredi 29 octobre 2025, le sud-est de Cuba. Rétrogradé en catégorie 3 (sur 5), mais avec des vents qui peuvent encore souffler à près de 200 km/h. L'ouragan a déjà provoqué «d'importants dégâts», assure le président cubain Miguel Diaz Canel. Plus de 700 000 personnes ont été évacuées.  Haïti, pour sa part, n'a pas été touchée directement par l'œil de l'ouragan, mais toute la moitié sud du pays est en alerte rouge, y compris la capitale, Port-au-Prince. Face à cela, les autorités haïtiennes ont déclaré, ce mercredi chômé, explique Gazette Haïti. Objectif : «permettre à la population de se préparer et de réduire les risques liés au passage de l'ouragan», poursuit le site d'information.   À lire aussiLa Jamaïque, «zone sinistrée» après le passage de l'ouragan Melissa Brésil : L'opération de police la plus meurtrière de l'histoire de Rio À Rio de Janeiro, une gigantesque opération de police ordonnée par le gouverneur Claudio Castro s'est soldée, mardi 28 octobre 2025, par au moins 132 morts. Ce mercredi matin, des dizaines cadavres ont été alignés dans la rue par les habitants eux-mêmes, dans l'un des quartiers visés par l'opération, écrit Folha de Sao Paulo sur son site. Les familles cherchent à identifier les victimes. D'après les autorités, les policiers visaient des membres du principal groupe criminel de la ville, le Comando Vermelho. À lire aussiScène de guerre à Rio de Janeiro: des dizaines de morts dans une opération anti-drogue

É um dos jovens cantores e compositores brasileiros mais estimados dos últimos anos, tanto a solo na banda O Terno. A poucas semanas dos concertos com orquestra em Portugal, Tim Bernardes vem Posto Emissor falar da colaboração com o maestro Martim Sousa Tavares e também da infância marcada pela descoberta de música muito diferente, bem como da admiração por artistas portugueses – já colaborou com Salvador Sobral e Capitão FaustoSee omnystudio.com/listener for privacy information.

In this inspiring episode of the PRovoke Media podcast, Maja Pawinska Sims talks to our Young Changemakers for 2025. The four amazing young women from underrepresented backgrounds around the world have been recognised as future leaders of the communications industry, in the fourth year of the competition: Liyana Shirin in London, Elsie Merhi in Dubai, Kayla Marrero in Washington DC and Lívia Gammardella in Sao Paulo, Brazil. Before the conversation with the Young Changemakers, we speak to the woman behind the initiative, We. Communications founder and global CEO Melissa Waggener Zorkin. 

Making progress on the energy transition, net zero sustainability, and inclusive growth requires an effort that transcends borders and means involving a wide range of parties including asset owners and policymakers. Jane Ambachtsheer, Global Head of Sustainability, talks to Daniel Morris, Chief Market Strategist, about the significance of this meeting, the PRI advocacy network and its principles for responsible investment, and what investors can expect from the PRI in Person in Sao Paulo, Brazil on 4 - 6 November 2025.For more insights, visit Viewpoint: https://viewpoint.bnpparibas-am.com/Download the Viewpoint app: https://onelink.to/tpxq34Follow us on LinkedIn: https://bnpp.lk/amHosted by Ausha. See ausha.co/privacy-policy for more information.

In this heartfelt and expansive episode of The Circle of Hope podcast, I sit down with my dear friend of over thirteen years, Felipe Ferreira. Our friendship began when our professional paths crossed in the hospitality industry—Felipe based in Sao Paulo and me in Texas. Over the years, despite having only met twice in person, we've grown an immensely supportive, curious, and genuinely reciprocal relationship spanning continents, time zones, and languages.Together, we explore what makes relationships thrive across cultures and professions. Felipe shares stories of his transitions—from bustling Sao Paulo to nature-loving Rio de Janeiro, and now to his new home in Germany. He opens up about the quirks and challenges of building community in different countries, the importance of “connection agents,” and how curiosity and intentionality shape lasting circles of influence. Throughout our conversation, we reflect on how to discern which relationships to nurture, how culture and language influence connection, and the power of being both a giver and a receiver in any relationship. Whether you're moving cities, countries, or just seeking deeper connections in your everyday life, Felipe's wisdom and our shared journey highlight the joy and impact of building your own circle of hope.Watch This If:You're moving to a new city or country and want tips on building authentic connectionsYou value cross-cultural friendships and work relationshipsYou're curious about maintaining strong, long-distance friendshipsYou want to know how to be more intentional with your social circleYou enjoy personal growth stories rooted in real-life experienceYou're navigating new work environments and looking for connection strategiesQuotes to Remember:“I think it's all about the exchange—so I receive a lot, I get a lot, but maybe I can give you a little bit as well.” – Felipe Ferreira“Don't ever take for granted that the people in your circle who are most beneficial… may not be your peers.” – Valerie Hope“A smile really opens doors. And even if you cannot communicate, people can really tell if your intentions are good.” – Felipe Ferreira“Letting people go is okay. There are some people that will come and go, and that's okay.” – Felipe FerreiraWhat You'll Learn:How to leverage curiosity to build strong, authentic cross-cultural friendshipsWhy professional connections can become deep sources of personal and emotional supportPractical ways to adapt your social life after relocating to a new city or countryThe importance of “connection agents” and how they help integrate you into new communitiesHow to discern which relationships deserve your time and energyStrategies for staying connected with friends and colleagues around the globeWhy being intentional about giving and receiving is key to thriving relationshipsLet's Stay Connected:Guest: Felipe FerreiraInstagram: https://www.instagram.com/felipeofLinkedIn: https://www.linkedin.com/in/felipeof/Facebook: https://www.facebook.com/felipeoferreiraHost: Valerie HopeWebsite:https://www.valeriehope.comInstagram:https://www.instagram.com/valeriehope/LinkedIn:https://www.linkedin.com/in/valeriehope/Facebook:https://www.facebook.com/ValerieVHopeYoutube:https://www.youtube.com/@ConnecttoJoyProduction Support: Lucy Hope - Podcast Editing, Copy, and Publishing.#CircleOfHope #CrossCulturalConnections #CircleOfInfluencers #FriendshipGoals #PersonalGrowth

Ahead of COP30, Brazil is positioning itself as a leader of the climate agenda, while moving ahead with increasing ambitions in oil exploration. Can the host of the UN's convention against global warming strike a balance? Join the talk between Camila Fontana, deputy bureau chief of the Argus office in Sao Paulo, and Brazil news editor Lucas Parolin, who will be covering the COP30 in Belem in November.

來抱怨一下巴西輸台灣的地方↓↓↓ (03:10) 抱怨時間 (10:40) 新賽季會爆發的球員 (21:50) 推歌時間～ ABRILA - Muy Mala、Key Glock - She Ready 別忘了小額贊助

Sarah Aswegan, a seasoned biopharma leader and strategic advisor for global rare disease solutions, shares her journey from sales in pharma to her consulting work today. She discusses her experience in transitioning biopharma companies from clinical to commercial success, the evolution of medtech in diagnosing and managing rare diseases, and the collaborative efforts required to bring innovative treatments to market. She also shares insights on current trends in gene therapy, the dynamics of funding, and the importance of data in advancing care for rare disease patients. Guest links: www.saraaswegan.com  Charity supported:  Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 065 - Sara Aswegan [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello and welcome back to another episode of The Leading Difference podcast. I'm your host Lindsey, and today I'm delighted to welcome to the show, Sarah Aswegan. Sarah is a seasoned biopharma leader helping organizations transition and grow from clinical to commercial success. She prides herself on the success of leading multiple global cross-functional teams and contributing to the success of the franchise areas she oversaw and served. Until recently, she's applied these experiences while serving in a consultancy capacity for many small to midsize biotechs entering or expanding in rare disease. She has also successfully helped organizations to start and scale adjacent spaces to biopharma, and most recently has been serving as a Global Head of Commercial Assets, Brands, and Care Solutions, and has led transformational change at UCP, having been part of the design and scale of the business unit for rare disease. She maintains a strong network among clinicians, access, bioethicists, and patient advocacy globally. Well, thank you so much for joining us today. I'm so excited to speak with you. [00:01:52] Sara Aswegan: Thanks, Lindsey. It's nice to be here. [00:01:54] Lindsey Dinneen: Wonderful. Well, I'd love, if you wouldn't mind, sharing a little bit about yourself and your background and what led you to medtech. [00:02:02] Sara Aswegan: Yeah, thanks Lindsey. You know, I, I started my career ages ago in the pharma side of things, and as my career has grown, so has the exposure across pharmaceuticals, into biotech and including aspects of medtech. As we look at some of the areas I've spent the last 18 years in rare disease, the medtech component is coming in largely around if we think about the diagnosis component and then the management of the different conditions over the lifespan of a child or adult affected by a rare condition. You can see things really evolving. I started my career on the sales side of things. My education is in business and communication, so anyone can learn the science if you have good mentors and people to help you along the way. And I was really, really fortunate to work amongst a team of amazing individuals, both in the US and then now having lived away for about 15 years outside of the US that have helped open my eyes to what can be possible and the differences by markets. And as I mentioned, I spent the last 18 years in the rare disease space really helping companies of all sizes build out and scale their teams, bringing in new assets and bringing solutions to the field of rare disease. And it's something I'm very passionate about. [00:03:06] Lindsey Dinneen: Yeah. Well, thank you for sharing a little bit about that. So I'm curious, that's a very specific niche and I would love to understand how you arrived at that and how you realized, "Oh, this is what I'm meant to be doing." [00:03:19] Sara Aswegan: Yeah. So I made a move geographically and company-wise to a small firm at the time. We were just a very small team. We called it the bootstrapping team at Shire Human Genetic Therapies, and I moved from the Chicago area to Boston, and that was my first really exposure to rare diseases. And, it's a completely different field and it continues to evolve even to this day. But the closeness and proximity you have to patients and their families and those with unmet need. And I have, you know, a couple of close friends as well as a family member that's been affected by a rare disease. So as you're seeking care and support for them, it's not always about the medications. It's about that total person and thinking really holistically about the individual and their care teams that are impacted by those conditions. So the external community we were serving really drove me and introduced me to something that I've stayed with, and it brings great passion to try to find ways to support individuals in our western society, but also looking at low middle income countries and helping facilitate diagnosis to treatment to, again, that whole supportive care and largely from the internal teams within the organizations I've worked with has just is been tremendously rewarding and also equally challenging. It's beautiful to see progress. I mentioned diagnosis and. One of the areas I worked in initially was in the lysosomal storage disease area. And it's the age-old question on diagnosis. Do you facilitate newborn screening, for example, so when your child is born, you have a heel prick done and you can do a series of tests depending on the state you live in, and in some countries in Europe it's also provided. But if there's not a therapy, is it okay to do that type of diagnosis support. And so that challenge, you know, in seeing the policy evolve on a state by state basis. When I began in the rare disease space and MPS Type Two Hunter Syndrome, it's a condition that affects mostly boys and a very small part of our population. We knew we could do newborn screening and there was a therapy available, but it wasn't only realized until a few years ago to introduce newborn screening to help those families at the point of birth to know if their child was affected, and therefore start a different trajectory on how they planned for care for them and plan for if there was a medication or other supportive tools and resources available for them. So it's been extremely dynamic to see how things have evolved. And then now as you see medical and pharma medical technology advance as well into gene therapies. You're seeing news about gene therapy and it's a one time treatment and then the individual hopefully will not have be re redos in their lifetime. Along with that come challenges on that diagnosis piece to make sure they're eligible for the gene therapy. So again, through the device and technology sector, it plays a key role. In addition to the supportive care that goes on for some of these really severe conditions, people have some pretty dynamic needs and it's great to see how things are progressing, but it's still as equally as frustrating, whether you're on the manufacturer side or the family side, to see things be kind of slow sometimes. [00:06:15] Lindsey Dinneen: Yeah, of course. And you're dealing with a specific situation where many times-- please correct me if I'm wrong-- but it seems like many times there's these kinds of studies and conditions are not funded very well in terms of finding solutions to the problem. So how is that something that you, well, first of all, of course we're in a very interesting season of life right now. So how are you seeing funding evolve over the years for these different diseases that are a little bit more rare, and what can we all do in terms of even just awareness and understanding? [00:06:51] Sara Aswegan: Yeah, so that's a huge question. We could probably have about five conversations on this just to scratch the surface, Lindsey. I think if I reflect on the question on what we've seen around funding, I mean there are some wonderful, supportive grants available for the brilliant scientists we have around the world that have a curiosity. So making sure we can facilitate that ongoing academic environment to explore and test the hypothesis. And one of the things that you see coming along, and it's not really around-- I won't think about funding as just pure financial-- but it's the funding of the smarts that go around the table. You see a lot more collaboration amongst academia, industry governments coming together to help build and scale so that there's an awareness and understanding of a condition. I mean, a pediatrician could go through their entire career and never see a boy with Hunter Syndrome. It's just that rare. At the same time, and on the converse of that, if you're working in an industry where you do have access to more funds, the introduction of AI and looking at how we look at drug targeting, drug target selection, genetics and precision medicine have come along quite leaps and bounds in the last several years, but we're still not quite there. But you're seeing advancements with the different cell and gene therapies, having that precision medicine as an option. It's coming forward. The challenge is the size of studies are normally very small because the population is small. So thinking about patient recruitment, how can we help facilitate better identification of individuals that may be out there and not have received diagnosis because of the rarity of the condition? So looking at technology and advancement of integrated electronic health records up to and including, how do we look at the trial designs? And how do manufacturers, academics, industry, and agencies work together to think a little differently around even designing clinical endpoints for the studies that really are meaningful, that will make a difference. And how do you balance that, right? Correct risk benefit conversation, in the spirit of doing no harm. But if there's one chance and there's something available, how do you do that? And coming all the way downstream. If you think about where the organizations have advanced their thinking, their approach, and put funds behind, it's also that ongoing care of the individuals. If you look at the upstream, the types of tests that are available. It could be cancer, it could be the area I am so passionate about in genetic disorders, but it can also be thinking about the workflows that come into play in helping facilitate consistency of care across state borders, across country borders. It's a key piece that are really advancing in real time, but we're still trying to overcome the hurdles that are real. And that's things around data privacy. How do we navigate that in a really meaningful way with the right ethics and integrity. If we think about the regulators, this isn't a huge anti-infective or cardiac study that's ongoing, that there are gonna be tens of thousands of people. So how can we think a little bit differently on advancing the care. In the area I'm working in, Lindsey, especially with some of these individuals that are kids, if they don't get access to care by a certain age point, their window of treatment has closed. And so what could we do to help facilitate earlier diagnosis and then that advanced care. And so I think we can see a lot of really good intentions, and I think the most beautiful thing is even the collective gathering of different patient organizations that have a shared interest of a disease coming together and also helping raise research funds to help support the scientists that have a hypothesis on something that may really make a difference and may matter. [00:10:21] Lindsey Dinneen: Yeah. Yeah. Okay, so, there has been so much innovation in the last few years-- of course, even before that, but it seems to be extremely exciting in the last few years-- especially things like CRISPR and all sorts of new technologies emerging. What are some of the exciting trends that you're seeing in this space specifically that give you hope as you continue to look forward and look for solutions? [00:10:45] Sara Aswegan: I think for me, I mentioned, I touched on it lightly. I think it's that collective, that collaboration and the openness now. The FDA has advanced the way that they think and engage with agencies as well as industry partners. And so what I mean by that, Lindsey, is they're not just engaging with the scientists or with the manufacturers, the drug developers. They're also bringing patients in. And so that collaborative environment, they're even beginning conversations when there's discussion on clinical trial design to understand what really matters. Is it a six minute walk test or is it something around real behavioral or other abilities that can be learned and retained over time that help benefit the quality of life? If you're not gonna be able to cure something, what's really important at that patient front to help facilitate something meaningful. So I think that type of conversation also with the agencies looking at, there was an amazing session held in Europe recently in the mucopolysaccharidosis or the lysosomal storage disease area, looking at advancements of science and saying, can we look at biomarkers alone and create that relationship and understanding there is a clinically meaningful impact if we can address this biomarker. And so, companies like Ultragenyx have really pushed to have that conversation and dialogue and have a drug filed now that's under review based on biomarker endpoints alone, where five years ago, you would never have imagined that being possible. [00:12:12] Lindsey Dinneen: Yeah. Yeah. You touched on something that I would really love to explore a little bit deeper, and that is, when there's a situation that right now we don't have a cure for this disease-- and, you know, obviously we're still working towards it-- but if we don't have a cure, but we are trying to improve the quality of life, how do you balance that in your specific field in terms of: obviously you want the patients to live the best quality of life that they can while balancing so many other, and I don't mean this in a callous way at all, just from a practical perspective, balancing all of these other considerations and things that are also desiring funding and all those competing priorities. So how do you balance that? How, how does that come into play? [00:12:57] Sara Aswegan: So that's a big one. It's a tough one. And I'll oversimplify it and just say data. And what I mean by that, Lindsey is really looking at, with the technology at our fingertips, regardless of the geography you're living in, there's a lot of meaningful information that can be captured. And it's not, again, around one aspect of a disease, but it's the totality of health. So really looking at what could be possible in capturing, is it around energy levels, activity levels. And you'll see that oftentimes in play with the gene therapy, for example, when it's administered, you may have up to 15 years of follow up that you're capturing specific data points. But even in advance of a drug approval, and an area I am also equally passionate about, is access to unlicensed medicines for individuals that can't travel to a clinical trial site and could benefit from an investigational therapy, how do we do that with the right balance in place? And part of that is data and having the willingness of a participant or family member to be so consented in and participating in the study for their child to share that data and share that real world data or real world evidence so that you can measure back and show what impact that drug or treatment or intervention has been having on the individual. So I think it's around that and figuring out how we can overcome some of the complexities and challenges that are real. Not everyone has electronic health records. There's still lots of paper-based offices out there. But in the meantime, there's a lot of advancements in technology. So how do you appropriately use that, that it's also not overburdensome for the individual, for the family as well, that you're doing what really matters and measuring back and having the right conversations with the individuals affected, the investigators, the clinicians, but then the regulators, and going back and sharing why this can be something to help substantiate. It's not your standard phase 1, 2, 3 clinical trial design. That's, yes, there's rigor, but it's a different way of looking at using data to help us advance our understanding of a disease and what's needed by the individual affected. [00:14:53] Lindsey Dinneen: Yeah. So, so when you're speaking with these families and or-- well, first of all, let me actually back up. Do you have direct communication with some of these families and patients that you're working with? [00:15:04] Sara Aswegan: Yes. [00:15:05] Lindsey Dinneen: Yeah. And so when that happens, how. How is it for you? I mean, this is such a challenging area that you have devoted your life to and to, and I'm so impressed with that. And, you're doing the work that's helping save lives and make a difference. But that must be really challenging from a personal level to have these difficult conversations. So how do you balance that as a practitioner and somebody who's desiring to help, but you also have this real life compassion and human being that you're trying to help? [00:15:38] Sara Aswegan: It's tough and it's tremendously rewarding. At the same time, I have so many patient stories I can share with you of meeting them and meeting 'em where they are. I made a trip to Sao Paulo, Brazil once, Lindsey, and met a family that were living in the favelas there, and their aim was to help raise awareness for Hunter's Syndrome because their son had been undiagnosed. They knew something was wrong. He was nonverbal. He had some physical presentation that you could understand. There was something going on, but the technology wasn't there for them. The access to the care center wasn't there for them to get a diagnosis. They were taking buses for hours to different clinics to figure out what's wrong with our son. And he finally received a diagnosis of Hunter Syndrome and they wanted to share the photos because kids with Hunter Syndrome do have some different dysmorphism. So there's something that's strange. They have a bossy forehead, or their bridge of their nose is a little different. Their bellies might be a little bit bigger. So if you start looking at all of these different clues and putting it together, you might suspect and go-- there's other things going on, for sure. So I'm oversimplifying this. However, getting a diagnosis for him by just raising awareness to other families of the physical presentation and what their experience was extremely meaningful for them. And on balance, a family in Florida that I met and their son was diagnosed at age 18 months because their grandmother had seen a program on Mystery Diagnosis and said, "That sounds like my grandson." And so creating the conversation and meeting people where they are is really important because you may have some individuals that are very aware of how drugs are developed and all of the rigor that goes through that to then others that just they don't understand that some drugs are intended for a specific indication, specific population, and helping explain why their child may not be eligible for a particular study. It's tough, and that's not my responsibility, but the clinical teams and the clinicians that are having those conversations. So it's listening and really coming with a open heart and mind and having empathy to help figure out how can you educate. It's even moving into gene therapy. What does gene therapy actually mean? What are the risks? I'm afraid this sounds like it's something so futuristic. What will this mean for my son or daughter in 10 years from now? And, we may not have all of the answers, but you know, science has advanced and it's that risk benefit that you have to exercise. But really it's that coming with compassion and a listening ear and understanding and being honest. And if I can't help, maybe there's someone else that can help or there's a, did you know, there's a clinic here or a center there and helping that network stay connected and thrive is really important. And also being their voice, Lindsey, I mean, we can, we have an opportunity on our pharma, biomedtech side of the world that we can share what we've observed and try to apply that as we come to work every day and think about that family we met in Brazil or in Boston or in Florida or in, you know, Frankfurt, and whatever they may be experiencing. So it's being their advocate in other areas as well. [00:18:34] Lindsey Dinneen: Yeah, exactly. So with what you deal with, I am wondering what kinds of misconceptions or myths do you often encounter that are interesting and yet you would prefer to correct so that those of us in the general population are more informed? [00:18:52] Sara Aswegan: That's a good one. So I think having worked in the rare disease space, one of the biggest scrutinies there, there's on two sides of the coin. One is around diagnosis and why we can't do more around diagnosis. And sometimes the science is just not there yet. So again, to some of these experiences, like the story of the family in Brazil, it may not be about a blood test. It may be about a physical appearance and helping people piece things together. I think on the other end is at the point of delivery of the diagnosis and then if there is a treatment or intervention that can be taken, and not everyone has the same principle in their heart. There are companies that are motivated for different reasons, but certainly the big topic is are around drug prices, whether it's a gene therapy or a chronic lifetime medication, of how do we navigate that and how do we navigate that in a better way? And I think we have to start looking as an industry, as a community of people, of how do we address that? The cost of doing a clinical trial is tremendous. It's hugely expensive. Does it warrant though huge price tags on drugs forever in perpetuity? What's that right balance? And I think having a level of social responsibility and looking at alternatives. And so imagine if we could reduce the time for clinical studies for requirements because we're able to look at other data. Things like the biomarker approach and the follow on real world data that could be captured, could that help us in the total overall offering and the cost to the overall health system? Maybe. I think that as an industry, every company operates with different principles and wanting to do best for the patient community. Some are more profit driven than others, and so that's a reality, and it's one that I get so often at dinners with friends or in personal conversations, professional conversations, and it's a tough one. At the same time, a study of 60 individuals could be double digit millions of dollars. Just the cost of facilitating the study, the production costs of some of these highly technical compounds of different therapies also becomes a factor. So you have to put all these pieces together and really explore what's driving that. [00:20:57] Lindsey Dinneen: Yeah, of course. And yes, I'm sure that's a really difficult conversation to have too, when you're especially working directly with patients and trying to explain all of that and that's a lot. That's a challenge. [00:21:10] Sara Aswegan: Yeah. Yeah. [00:21:11] Lindsey Dinneen: But on the flip side, you know, of course the work that you do makes a huge impact, and I'm wondering if there are any stories that come to mind that just really reinforced to you, "You know what? I am in the right place at the right time, in the right industry." [00:21:25] Sara Aswegan: Absolutely. And I think it goes to, I touched on it very briefly, and there are people that aren't living in near major cities, near major medical centers, and that should not make them obsolete from receiving the best care. And there are two things that have happened and partly because of the pandemic, but also partly because of the willingness to educate and have that connected community amongst clinicians, is around that access to unlicensed medicine and finding pathways that it's not just because a doctor says your son or daughter needs this medication. I'm going to reach out to the manufacturer to see if I can get access because they're not near a clinical trial site or they don't wanna participate, or they're unable to participate in a study. But finding means to do that. And there have been some really creative ways that clinicians have been able to do that, of setting up qualified treatment centers where the individual can go to receive the treatment and then that continuity of care is provided then over the life of their disease. It's something that's become real and meaningful, and you would be shocked at the number of individuals around the world that are receiving access to medicines that normally might have only 10 years ago been available if you were living in the Western Europe or the United States because studies weren't conducted in their country and so there's no pathway for access that is all changing. Those dynamics are changing. It takes a team of people, though. It takes regulators, it takes lawmakers, it takes industry. It takes our logistics teams to be sure if something's stored at cold chain, that that product is delivered in the right context at the right time, just in time for that patient to receive it. So it's a complex challenge, but it's one that we've seen serve individuals in a really meaningful way. And without that, they wouldn't have, they wouldn't have another option. [00:23:11] Lindsey Dinneen: Yeah. So having that impact and just being able to reinforce in those moments of maybe when it's especially difficult or you're especially frustrated like, "Oh my gosh, I wish I could help X, Y, and Z," at least you can look back and go, "Yes, but look at all this that we are doing." [00:23:26] Sara Aswegan: You know, Lindsey, also it's that education piece and being curious and asking questions. The scientific community and one of the lead leaders in the NPS community is in North Carolina, Joe Munzer. Dr. Joe Munzer, he's brilliant. And one of the initiatives that we started was something called a masterclass. And so with Dr. Munzer and seven or eight other clinicians from around the world, we literally went on an educational program around the world. And some of the individuals that had just come out of their postgraduate work, pediatric geneticists or neurologists meeting the number one or two people that know this space so well, being mentored by them. And now those individuals are facilitating their class, the same type of class in their local language to their local communities and creating that level of education and awareness. I mean, it's just to see that real impact over time. I actually get goosebumps just thinking back on the impact that has had. And you've got a community of clinicians that they're, I mean, there's a lot of needs still to study medical genetics. And so hopefully we have individuals that are scientifically interested and will continue that that journey so that they can be the next teachers across borders. That makes the difference. [00:24:37] Lindsey Dinneen: Yeah. Absolutely. Wow. Yeah. Thank you for sharing that. I was also getting goosebumps just listening to it because that's incredible ripple effect that you had and continue to have. That's amazing. [00:24:47] Sara Aswegan: Yeah. Yeah. [00:24:47] Lindsey Dinneen: Yeah. Oh man. Okay. Well, I could talk about this for a long time, but pivoting the conversation a little bit, just for fun. Imagine that you were to be offered a million dollars to teach masterclass on anything you want. It can be within your industry, but doesn't have to be. What would you choose to teach? [00:25:05] Sara Aswegan: Wow. That is a great question, Lindsey. A masterclass-- a million dollars-- a masterclass on anything I would want. I would be drawn to some of the advancements we're seeing in gene therapies, but I think that would be, I wanna try to serve a broader population. Do you know? I think it's, I think if I could look, I would do something around looking back on some of these, if you will use cases and best practices, to share those learnings, just because we know the impact that it will have and has had and continues to have. And not just on the scientific community, but it ripples down into the patient communities of asking that question of "what can be possible, how can we together." Instead of " no," it's actually, "yes and" or "no and" we hear something else, another construct. And really breaking it down to really enforce what I've talked about on several moments during our conversation today is it can't just be the manufacturer, the, or the developer. It can't just be academia. It can't just be health authorities or regulators. It's a collective community and it has to include that patient within that conversation to help for that learning and advancement and understanding. And so I think it's something around that, the best practices, use cases, and really things that made a difference. Meeting people where they are of a good understanding of the science, not good understanding of the science, that crosses all levels. Drug development overall. The total continuity of care for my individual affected. It's not just about a drug, but it's about assistive devices or other tools that they can have a better life. And so being really thoughtful about that I think would be something that would be really amazing. That it's actually captured and taught back. [00:26:47] Lindsey Dinneen: Yeah, absolutely. That would be a fantastic masterclass. All right, and then how do you wish to be remembered after you leave this world? [00:26:56] Sara Aswegan: Well, at some point I know my husband will admit I have the best sense of humor. [00:27:01] Lindsey Dinneen: Yes. [00:27:02] Sara Aswegan: I think for me, Lindsey, I really would hope that people would say an open heart, a generous heart, and just a connector of people, personally, professionally. It takes two seconds to be kind and open and nobody has all the answers. So help people connect with others and be willing to say, "How can I help?" [00:27:20] Lindsey Dinneen: Yeah, absolutely. Yeah. And then final question, is one thing that makes you smile every time you see or think about it? [00:27:31] Sara Aswegan: I just came in from my garden and I have to say, seeing my advancement of fostering my garden and I've got things blooming now. There is hope. [00:27:40] Lindsey Dinneen: I love that. I feel that way every time I somehow succeed in keeping a plant alive. [00:27:45] Sara Aswegan: There is hope. It's really around the simple things, right? That's it. [00:27:49] Lindsey Dinneen: Yeah, absolutely. Now, for any of our listeners who are excited to get to know about you and your work a little bit more, can you just share briefly what is it that you do right now to help companies succeed and how can people get in touch with you? [00:28:02] Sara Aswegan: Thanks, Lindsey. So I am currently doing some advisory board work for a couple of consultancies as well as helping some small and mid-sized biotechs figure out their pathway and how they go to market. How do they facilitate access to unlicensed medicines? I'm passionate about the rare space, so I'm serving also on a couple of special projects on getting drugs and diagnostics into low middle income countries. And it's something I'm very passionate about and I've got a great network of people. So if I can't help, I'm always happy to say, "Not me, however, I know someone you should talk to." And to get in touch, it's not easy to spell, but it's www.saraaswegan.com. And again, if I can't help, I might know someone who can. And I think it's just, it's really good to share our knowledge and experience and really make a difference however we can. [00:28:47] Lindsey Dinneen: Yeah. Absolutely. Well, thank you, Sara. This has been absolutely incredible to learn from you, to hear about your story. So thank you for sharing and being open. I really appreciate that. And my goodness, I just wish you the most continued success as you work change lives for a better world. [00:29:03] Sara Aswegan: Thanks Lindsey, and thanks for everything you're doing. Really, hats off. Thanks a million. [00:29:07] Lindsey Dinneen: Of course, and have the best rest of your day. And thanks also to our listeners for tuning in. If you're feeling as inspired as I am right now, I'd love it if you shared this episode with a colleague or two and we'll catch you next time. [00:29:22] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

From the BBC World Service: The decision at Toyota in Brazil comes after intense storms halted production at its factories in the state of Sao Paulo, and many of the workers will be paid in full during the closed period. Hackers have attempted to recruit the BBC's cyber correspondent into helping them infiltrate the broadcaster's systems. And has Canada lost in the trade war with the U.S.? Over the past month, it's removed billions of dollars in retaliatory tariffs on American goods.

From the BBC World Service: The decision at Toyota in Brazil comes after intense storms halted production at its factories in the state of Sao Paulo, and many of the workers will be paid in full during the closed period. Hackers have attempted to recruit the BBC's cyber correspondent into helping them infiltrate the broadcaster's systems. And has Canada lost in the trade war with the U.S.? Over the past month, it's removed billions of dollars in retaliatory tariffs on American goods.

26-09-25 - Programa Seguinte Apos Eliminacao do Sao Paulo na Libertadores - Programa Nr 6909

Joining the show today is Candice Smithyman, an international prophetic revivalist, author and host of the Glory Road TV show, Rebekah Green,an interpreter of dreams for leaders, including government officials, and Lu Batchman, leader/president of the A Million Women Brazil movement! Hear about the upcoming event One Million Women - Brazil, October 25 in Sao Paulo, Brazil! Learn the significance of the timing and dates of the event, and why this is a critical time for Brazil! Go to amillionwomen.org for more information.

Nathan Sexer is the head of Devcon and Devconnect at Ethereum Foundation, and Romina Sejas runs ETH Kipu - host of the annual ETH Latam eventIn this conversation we discuss how Latin America will be the center of the crypto universe this November when Devconnect, the premier Ethereum developer gathering, comes to Buenos Aires and ETH Latam comes to Sao Paulo. These events will be a coming of age moment for the region as the crypto world grasps the importance and potential of these technologies in places like Brazil and Argentina-------------------------------------------------------------------

Join Kate Stanton Melendez for an interview with soft sculpture artist, performance artist, and college professor Kelly Boehmer.    Kelly has exhibited and performed her work nationally and internationally in over 175 exhibitions including shows in Baltimore, Dallas, Miami, New York City, New Orleans, Pittsburgh, San Juan, Sao Paulo, Brazil, Gimpo-si, Gyeonggi-do, Korea and Sarajevo, Bosnia and Herzegovina.  She received her BFA in Studio Art at the Maryland Institute College of Art and her MFA in Studio Art at the University of South Florida. She is a member of the performance art band, Glitter Chariot. Kelly is a Professor of Foundations Studies at Savannah College of Art and Design, in Savannah, GA.   Boehmer's soft sculptures combine tragic humor with a celebration of the hidden beauty found within anxiety. Her creatures serve as metaphors for personal struggles with anxiety and aging. She finds humor in her attempts to become "comfortable in my own skin" and to navigate these challenges, particularly with social anxiety. Though the imagery may appear grotesque, with flayed and molting forms, these creatures represent growth, transformation, and positive change. She uses glittery sheer fabrics and vivid faux fur, to contrast difficult emotions with inviting textures. This creates a tension between attraction and repulsion, softening the rawness of the subject matter and making it more approachable for the viewer. Many of her works draw inspiration from iconic pieces in art history, such as the Unicorn Tapestries, the Laocoön Group, Lion Hunt of Ashurbanipal, and The Arnolfini Portrait. Her aggressive hand-sewing technique is similar to an expressive line in drawing. A key element of the process involves repurposing materials from previous sculptures, cutting them up after an exhibition and combining them with upcycled taxidermy. This gives the materials a “second life,” creating a layered history of growth and change embedded within the pieces themselves.   Check out Kelly's work here: https://www.kellyboehmer.com/ Kelly Boehmer (@kelly.boehmer) • Instagram photos and videoshttps://www.instagram.com/kelly.boehmer/?hl=en   Buy Kelly's work from Cindy Lisica Gallery in the Atlanta Art Fair: https://artcloud.market/show/cindy-liscia-gallery-atlanta-art-fair   See her husband Chuck Carbia's work here: https://www.chuckcarbia.com/

U.S. interventions in Brazilian politics since the 19th century & Bolsonaro's 27-year prison term. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

AGENDA: IntroGanadores torneos del fin de semana.Iva Jovic campeona del WTA 500 de Guadalajara. Tiantsoa Rakotomanga campeona del WTA 250 de Sao Paulo. Preview de la Laver CupNueva sede en San Francisco (estadio de los Golden State Warriors)Explicar el formato de la Laver Cup, puntaje, etc.Members de cada equipo + alternates + capitanes.Quien ha ganado las ediciones pasadas.Torneos esta semanaY más ...Instagram: @TennisPiochasTwitter: @TennisPiochasTikTok: @tennis.piochas Distribuido por Genuina Media Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In 2012, inside a quiet luxury apartment in Sao Paulo, a couple sat down to confront their marital trust issues. What began as a tense conversation between husband and wife quickly spiraled into violence and horror and what followed left an entire nation stunned. Was this the desperate act of a woman defending herself from abuse or the calculated crime of a cold-blooded killer?Sources:Elize Matsunaga: Once Upon a Crime. Netflix, 2021.Newsweek. “Who Is Elize Matsunaga? The True Story Behind Netflix's Once Upon a Crime.” July 7, 2021.Esquire. “Elize Matsunaga Shot and Dismembered Her Husband—Here's Where She Is Now.” July 14, 2021.The Independent. “Netflix's Elize Matsunaga: Once Upon a Crime — the true story.” July 8, 2021.Radio Times. “True story behind Netflix's Elize Matsunaga: Once Upon a Crime.” July 7, 2021.Folha de S.Paulo. “Em vídeo, Elize Matsunaga conta como matou o marido.” August 26, 2012.TV Globo — Fantástico. “Vídeo de Marcos com outra mulher pode ter provocado briga.” 2012.TV Globo — Fantástico. “Julgamento de Elize Matsunaga.” 2016.BBC News Brasil. “Quem é Elize Matsunaga, condenada por matar e esquartejar o marido.” July 2021.General Mills. “General Mills to Acquire Yoki Alimentos S.A.” Press release, May 24, 2012.This Week's Episode Brought to You By:Shopify - $1 per month trial - http://shopify.com/lovemurderHiya - 50% off your first order - http://hiyahealth.com/lovemurderFind LOVE MURDER online:Website: lovemurder.loveInstagram: @lovemurderpodTwitter: @lovemurderpodFacebook: LoveMrdrPodTikTok: @LoveMurderPodPatreon: /LoveMurderPodCredits: Love Murder is hosted by Jessie Pray and Andie Cassette, researched by Sarah Lynn Robinson and researched and written by Jessie Pray, produced by Nathaniel Whittemore and edited by Kyle Barbour-HoffmanSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Check out our website... https://www.talking-tennis.com/ Subscribe to our podcast... Spotify: https://open.spotify.com/show/43f2LvpQA7rxGbaRXqRMxH Apple Podcasts: https://podcasts.apple.com/de/podcast/talking-tennis/id1652349752 Amazon Music: https://podcasters.amazon.com/podcasts/1e8c717a-0be6-4145-adf5-aee32501a1ae Follow us on... Twitter: https://x.com/talkingtennis22 TikTok: https://www.tiktok.com/@talkingtennis Instagram: https://www.instagram.com/talkingtennistt/ Talking Tennis merchandise: https://my-store-d73955.creator-spring.com/ Rakotomanga Rajaonah eclipses Tjen in São PauloWinner: 19-year-old Tiantsoa Sarah Rakotomanga Rajaonah (France) won her first WTA Tour title by defeating Janice Tjen (Indonesia) 6-3, 6-4 in the final of the SP Open (WTA 250) in São Paulo. It was the inaugural edition of the São Paulo Open, marking the WTA's return to the city after a long absence. Rakotomanga Rajaonah was outside the top 200 before the tournament; her win vaults her up in the rankings to a career high of No. 131. Key stats/factors:She converted 4 of 8 break point chances, while Tjen managed only 2 of 10. Rakotomanga Rajaonah didn't hit an ace in the final, and committed five double faults, but her serve percentages and second-serve resilience were strong. Tjen had a strong first-serve performance, but she struggled significantly on her second serve. Jovic wins GuadalajaraWinner: 17-year-old Iva Jovic (USA) picked up her first WTA title at the Guadalajara Open Akron (WTA 500 event), beating Emiliana Arango (Colombia) 6-4, 6-1 in the final. With this win, Jovic becomes the youngest winner on the WTA Tour this season. She had to battle in earlier rounds, including saving multiple break points and pushing through some tight matches. In the final, she dominated from the return, saved break points, and used momentum well. The victory also gives a large boost in prize money (~US$164,000) and ranking points, moving her significantly up in the race. Seoul Preview (Korea Open 2025)Here's what to look out for as the tour shifts to Seoul:The Korea Open Tennis Championships in Seoul are a WTA 500 event, outdoor hard courts. Prize money is ~$1,064,510, and a strong field is expected. Key players / seedsIga Świątek — World No. 2, top seed; she's making her Seoul debut. Amanda Anisimova — Seeded high; coming off strong results. Ekaterina Alexandrova — Former Seoul champion, familiar with the conditions. Clara Tauson, Daria Kasatkina, Beatriz Haddad Maia (defending champ), Emma Raducanu among others — mix of experience and rising forms. What to watch / storyline anglesWhether Świątek can break her WTA 500 title drought — she hasn't won a 500-level since Stuttgart 2023. The defending champion Haddad Maia will be looking to defend points and maintain momentum. The wildcard entries (especially local players) might shake things up; local crowd support could matter. Rising players might use this as a springboard late in the season (for rankings, confidence, etc.) Learn more about your ad choices. Visit podcastchoices.com/adchoices

El juez Alexandre de Moraes, instructor del juicio contra el expresidente brasileño Jair Bolsonaro por golpismo, ha propuetso una pena de 27 años y tres meses de prisión para el exmandatario. Analizamos qué supone con Claudio Gonçalves Couto, doctor en Ciencia Política y profesor de la Fundación Getulio Vargas de Sao Paulo.Escuchar audio

L'ancien président brésilien Jair Bolsonaro a été condamné ce jeudi (11 septembre 2025) à 27 ans de prison. Le politique d'extrême droite a été reconnu coupable de tentative de coup d'État, comme 7 autres accusés. Une décision historique dans l'histoire de la République brésilienne. Les précisions de notre correspondante Sarah Cozzolino.  En Une du quotidien O Globo, Jair Bolsonaro semble déjà être derrière les barreaux. Sur son site, le quotidien de Rio de Janeiro revient sur cette décision historique : «Le Brésil rend des comptes à l'Histoire, en faisant ce que le pays n'avait pas réussi à faire après la dictature militaire de 1964.» Pour la Folha de Sao Paulo, la condamnation de Jair Bolsonaro est juste, mais la peine est exagérée, au regard surtout de l'état de santé de l'ancien président. Pour le journal, il n'y a pas à se réjouir de la décision d'hier, «car lorsqu'un régime doit recourir à des peines drastiques comme l'emprisonnement d'un dirigeant, c'est que tous les mécanismes de prévention ont failli». Un discours dans la presse des États-Unis, où, pour le New York Times, le Brésil vient de réussir là où les États-Unis ont échoué. Le quotidien souligne le contraste entre la décision prise contre «le putschiste Bolsonaro», et la situation américaine, où le président Donald Trump, qui avait également tenté d'annuler une élection, n'a pas été envoyé en prison, mais rappelé à la Maison Blanche. Un photographe dans la prison géante salvadorienne  Le photographe américano-salvadorien Juan Carlos s'est rendu à 5 reprises dans le Cecot, la prison de haute sécurité très controversée voulue par le président Bukele. Le photographe y a aussi passé une nuit. Des cellules où la lumière ne s'éteint jamais, les lits sans matelas, la sortie de 45 minutes dans le couloir de la prison pour faire du sport ou écouter la Bible. Marine de La Moissonnière l'a rencontré au festival Visa pour l'image.  À écouter aussiÀ la Une: plongée dans les prisons de l'horreur au Salvador   La Sainte-Lucienne Julien Alfred aux championnats du monde d'athlétisme à Tokyo Elle avait créé la sensation l'an dernier (2024) en surclassant tout le monde en finale olympique du 100 mètres. Elle avait écrasé la concurrence en 10 secondes et 72 centièmes pour remporter ce titre devant les Jamaïcaines et les Américaines, à la surprise générale. Elle vient de Sainte-Lucie, un tout petit pays dans les Caraïbes, situé entre la Martinique et la Barbade, une île de moins de 200 000 habitants, qui s'est révélée aux yeux du monde, grâce aux performances de la sprinteuse désormais âgée de 24 ans. Les précisions de notre journaliste à Tokyo, Cédric de Oliveira.   À lire aussiAthlétisme: Julien Alfred de retour sur 100 m, Duplantis vise haut à Oslo Aux États-Unis, la téléconsultation pour contourner l'interdiction d'avorter Trois ans après la suppression du droit fédéral à l'IVG, le nombre d'interruptions de grossesse n'a pas diminué, au contraire, il est même au plus haut depuis 10 ans. Et non seulement il y a beaucoup d'avortements, mais il y en a aussi dans les États qui l'ont interdit, grâce à ce que l'on appelle le téléavortement. Les précisions dans l'enquête d'Aurore Lartigue sur le site de RFI.   À lire aussiComment la télémédecine a révolutionné l'accès à l'avortement aux États-Unis Les images de l'assassinat de Charlie Kirk partout sur les réseaux  Alors que de nombreux journaux reviennent sur les possibles conséquences de cet événement sur la banalisation de la violence politique, le bimensuel WIRED, un magazine spécialisé dans les nouvelles technologies, revient sur la responsabilité des plateformes en ligne dans la propagation d'images violentes à grande échelle.  En l'occurrence, la vidéo de l'assassinat de Charlie Kirk, qu'on retrouve très facilement, filmée sous tous les angles, sur n'importe quel réseau social. Il suffit de ne pas avoir désactivé la lecture automatique pour voir, sans le vouloir, l'instant où la balle touche le militant. Pour le magazine, Charlie Kirk a été abattu dans «un monde post-modération de contenu», dans lequel les principales plateformes manquent à leurs obligations. Il rappelle que depuis deux ans, les réseaux sociaux X, TikTok, Facebook et Instagram réduisent considérablement leurs efforts de modération de contenu. Et passent de modérateurs humains, «une ligne de défense essentielle pour protéger les utilisateurs contre les contenus préjudiciables» selon Wired, à une modération par intelligence artificielle. La vidéo peut alors passer entre les mailles du filet. À ce jour, elle a été vue des millions et des millions de fois. une violence banalisée, accessible et lourde de conséquences. Wired cite des internautes qui, en réponse à la vidéo, tweetent : «Félicitations, vous m'avez radicalisé.» Les plateformes, elles, se gardent de répondre aux questions sur leur responsabilité. À lire aussiAssassinat de Charlie Kirk: le gouverneur de l'Utah dévoile l'identité du suspect arrêté Au Canada, le recul de Mark Carney sur l'environnement  Le Premier ministre canadien Mark Carney a dévoilé jeudi (11 septembre 2025) cinq grands projets d'intérêt national qu'il veut réaliser rapidement, dans le cadre de sa controversée loi visant à bâtir le Canada. L'objectif est clair : réduire la forte dépendance du Canada au marché américain. Pendant la campagne, le mantra du candidat libéral, c'était «Build, baby, build». Il le met désormais en action avec deux projets d'exploitation minière, l'agrandissement d'une usine de gaz naturel liquéfié, la construction de réacteurs nucléaires. Pour le quotidien québécois Le Devoir, les projets de Mark Carney mettent de côté la protection de l'environnement et confirment «le décevant manque d'audace climatique du Premier ministre issu du monde économique». D'ailleurs, pour le Globe and Mail, Mark Carney dirige la politique économique comme un conservateur. Selon le journal de Toronto, bon nombre des mesures prises par Mark Carney reflètent l'esprit des propositions du Parti conservateur de Pierre Poilievre, notamment sur la remise en question de certaines réglementations environnementales. Ce qui fait dire au Devoir que, sous Mark Carney, l'ambition environnementale libérale équivaut à un rétropédalage climatique. La 1ère  La «réorientation» d'une partie des fonds européens destinés à la banane vers une aide à la diversification agricole en Martinique continue à faire parler d'elle aux Antilles.  À écouter aussiLa banane française en difficulté

來聊一點巴西的生活↓↓↓ (Eric音質因網路關係有點差，請見諒) (05:30) 有跟林書豪接觸過嗎? (09:00) 有遇過台灣人在巴西嗎? (16:00) 巴西女生超正 (22:00) 聖保羅治安有點差 (41:20) 推歌時間～ 美秀集團 - 愛情的大壞蛋 別忘了小額贊助

The Franchise Podcast is back with Canelo vs Crawford, and some AFC West Football!Watch The Mashup Episode with The Main Event's Kalani Lua and The Front Page Podcast's Towan Butler at https://franchisesportsmedia.com/the-franchise-podcastSubscribe to our YouTube Channel at https://www.youtube.com/c/franchisesportsmediaThis week we've got a mashup between 3 hosts of 3 different podcasts ahead of a BIG fight weekend in Las Vegas! Kalani Lua (@klua11) from FSM's Main Event joins TQ along with Towan Butler from the Front Page Podcast (⁨@FrontPagePodcast-q2m⁩ on YouTube), and we're talking Canelo vs Crawford. The fellas give their takes on who'll win and why, in a fight that none of us thought we'd actually see. We also delve into some AFC West football as we have kidnapped a Chiefs fan in hopes that he would stand on bidness about his team's unfortunate turn of events in Sao Paulo. We were sadly mistaken.

Ben previews the WTA 250 event in Sao Paolo, Brazil. Alex Eala is coming in after winning her first WTA 125 title in Guadalajara last week. Can she level up and win her first WTA 250 this week? Tell us your predictions in the comments! ❤️ SUBSCRIBE TO GTL: https://bit.ly/35JyOhz ▶️ JOIN YOUTUBE MEMBERSHIP: https://bit.ly/3Fk9rSr

Amanda e Silvia deram vida a uma verdadeira cafeteria siciliana em Indaiatuba, no interior de São Paulo.Uma linda história totalmente feminina em que mãe e filha decidiram resgatar juntas suas origens sicilianas, abrindo um local onde tudo é feito de forma artesanal - do café ao cannolo - com receitas autênticas da Sicília. Sicília, onde tudo começou, de onde vem a família Lamonica e para onde Amanda decidiu se mudar, mais especificamente para Ragusa, para começar uma nova vida entre passado e futuro, levando ao Brasil as verdadeiras tradições sicilianas e à Sicília um pouco da inovação, entusiasmo e vontade de fazer típicos dos brasileiros.

A huge demonstration has taken place in the Brazilian city of Sao Paulo to denounce the Supreme Court trial of the former president, Jair Bolsonaro. He's accused of plotting a failed military coup against President Luiz Inacio Lula da Silva after losing his bid for re-election nearly three years ago. He denies the charges. The court is widely expected to convict Mr Bolsonaro in the next few days. Also: Zelensky condemns "ruthless attack" after Russia hits main government building in Kyiv, and have you seen the Blood Moon - a total lunar eclipse? The Global News Podcast brings you the breaking news you need to hear, as it happens. Listen for the latest headlines and current affairs from around the world. Politics, economics, climate, business, technology, health – we cover it all with expert analysis and insight. Get the news that matters, delivered twice a day on weekdays and daily at weekends, plus special bonus episodes reacting to urgent breaking stories. Follow or subscribe now and never miss a moment. Get in touch: globalpodcast@bbc.co.uk

The Chiefs open the 2025 NFL Season as a 3-Point favorite against the Chargers in Sao Paulo, Brazil. It's time to actually break down the game.Jeff Chadiha (NFL Network/NFL.com/@JeffriChadiha), Sam McDowell (Kansas City Star/KCStar.com/@SamMcDowell11) and Soren Petro (Sports Radio 810 - WHB/810whb.com/@SorenPetro) welcome James Palmer (The Atheltic's Scoop City & 89 with Steve Smith Podcast/@JamesPalmerTV) to fill in for Sam (In Brazil with the Chiefs) on the Podcast. They discuss…- Biggest challenge the Chargers present is..- Will the Chiefs go downfield?- Expectations for Simmons and Suamataia are…- Impact on Chargers losing Slater?- Have the Chargers put enough around Justin Herbert?- Will the Chiefs DL hold up?- Can LA expose the Chiefs secondary?- Keys to the game?- Predictions!!!

Daniel Jeremiah, Bucky Brooks and Rhett Lewis kick off the show previewing the first game of the 2025 NFL season as the Cowboys take on the Super Bowl champion Eagles. They analyze how the loss of Micah Parsons will impact Dallas’ chances of slowing down the Eagles dynamic offense and break down what the next step of Vic Fangio’s defense will look in 2025. (1:27) Then, they head to Sao Paulo, Brazil where the Chargers host the reigning AFC Champion Kansas City Chiefs.. The guys detail how Patrick Mahomes continues to elude defeat despite Justin Herbert seemingly doing his part and analyze what the Chargers need to do different to leave Brazil with a victory. (13:26) Move the Sticks is part of the NFL Podcasts Network.See omnystudio.com/listener for privacy information.

𝐎 𝐂𝐚𝐩𝐨𝐥𝐨𝐠𝐚̃𝐨, 𝐞𝐥 𝐩𝐨𝐝𝐜𝐚𝐬𝐭 𝐬𝐨𝐛𝐫𝐞 𝐞𝐥 𝐩𝐚𝐫𝐭𝐢𝐝𝐨 𝐞𝐧 𝐒𝐚𝐨 𝐏𝐚𝐮𝐥𝐨 𝐝𝐞 𝐥𝐚 𝐍𝐅𝐋, 𝐜𝐨𝐧 𝐄𝐬𝐭𝐞𝐛𝐚𝐧 𝐆𝐚𝐫𝐜𝛊́𝐚 ¡Arrancamos aventura! Este año estaremos en el encuentro que enfrentará a los Kansas City Chiefs y Los Angeles Chargers en Sao Paulo, y para ello, contaremos con Esteban García como corresponsal. En el segundo episodio, os contamos todas las novedades de los dos entrenamientos previos al encuentro y os contamos algunas curiosidades de los días previos al partido en Brasil. 𝗦𝘁𝗿𝗶𝗽𝗲𝘀, 𝘁𝘂 𝗮𝗴𝗲𝗻𝗰𝗶𝗮 𝗱𝗲 𝘃𝗶𝗮𝗷𝗲𝘀 𝗱𝗲𝗽𝗼𝗿𝘁𝗶𝘃𝗼𝘀 stripes.es 𝐑𝐨𝐜𝐤 & 𝐁𝐥𝐮𝐞𝐬, 𝐞𝐥 𝐥𝐮𝐠𝐚𝐫 𝐩𝐚𝐫𝐚 𝐝𝐢𝐬𝐟𝐫𝐮𝐭𝐚𝐫 𝐝𝐞 𝐥𝐚 𝐦𝐞𝐣𝐨𝐫 𝐦𝐮́𝐬𝐢𝐜𝐚 𝐞𝐧 𝐙𝐚𝐫𝐚𝐠𝐨𝐳𝐚 𝐇𝐚𝐫𝐝 𝐑𝐨𝐜𝐤 𝐂𝐚𝐟𝐞́ 𝐁𝐚𝐫𝐜𝐞𝐥𝐨𝐧𝐚: 𝐋𝐚 𝐦𝐞𝐣𝐨𝐫 𝐜𝐨𝐦𝐢𝐝𝐚 𝐚𝐦𝐞𝐫𝐢𝐜𝐚𝐧𝐚 𝐣𝐮𝐧𝐭𝐨 𝐚 𝐫𝐞𝐥𝐢𝐪𝐮𝐢𝐚𝐬 𝐝𝐞𝐥 𝐑𝐨𝐜𝐤 Twitter: @ElCapologist Twitch: https://www.twitch.tv/elcapologist Youtube: https://www.youtube.com/watch?v=br4bwIXvCjE&;;;;t=811s

In the latest episode of the NFL Fantasy Football Podcast, Marcas Grant, Michael F. Florio, and LaQuan Jones preview the two kickoff games on Thursday and Friday night with the Cowboys visiting the Eagles and the Chiefs facing the Chargers in Sao Paulo, Brazil. (2:14) Then, they discuss the biggest fantasy questions surrounding the rest of the Week 1 matchups. (7:02) Finally, each host shares their Must-Start of the Week (12:15) and Sleeper of the Week! (21:20) The NFL Fantasy Football Podcast is part of the NFL Podcast Network.See omnystudio.com/listener for privacy information.

𝐎 𝐂𝐚𝐩𝐨𝐥𝐨𝐠𝐚̃𝐨, 𝐞𝐥 𝐩𝐨𝐝𝐜𝐚𝐬𝐭 𝐬𝐨𝐛𝐫𝐞 𝐞𝐥 𝐩𝐚𝐫𝐭𝐢𝐝𝐨 𝐞𝐧 𝐒𝐚𝐨 𝐏𝐚𝐮𝐥𝐨 𝐝𝐞 𝐥𝐚 𝐍𝐅𝐋, 𝐜𝐨𝐧 𝐄𝐬𝐭𝐞𝐛𝐚𝐧 𝐆𝐚𝐫𝐜𝛊́𝐚 ¡Arrancamos aventura! Este año estaremos en el encuentro que enfrentará a los Kansas City Chiefs y Los Angeles Chargers en Sao Paulo, y para ello, contaremos con Esteban García como corresponsal. En el primer episodio, os contamos todas las novedades, como está la ciudad y los días previos al partido en la ciudad paulista. 𝗦𝘁𝗿𝗶𝗽𝗲𝘀, 𝘁𝘂 𝗮𝗴𝗲𝗻𝗰𝗶𝗮 𝗱𝗲 𝘃𝗶𝗮𝗷𝗲𝘀 𝗱𝗲𝗽𝗼𝗿𝘁𝗶𝘃𝗼𝘀 stripes.es 𝐑𝐨𝐜𝐤 & 𝐁𝐥𝐮𝐞𝐬, 𝐞𝐥 𝐥𝐮𝐠𝐚𝐫 𝐩𝐚𝐫𝐚 𝐝𝐢𝐬𝐟𝐫𝐮𝐭𝐚𝐫 𝐝𝐞 𝐥𝐚 𝐦𝐞𝐣𝐨𝐫 𝐦𝐮́𝐬𝐢𝐜𝐚 𝐞𝐧 𝐙𝐚𝐫𝐚𝐠𝐨𝐳𝐚 𝐇𝐚𝐫𝐝 𝐑𝐨𝐜𝐤 𝐂𝐚𝐟𝐞́ 𝐁𝐚𝐫𝐜𝐞𝐥𝐨𝐧𝐚: 𝐋𝐚 𝐦𝐞𝐣𝐨𝐫 𝐜𝐨𝐦𝐢𝐝𝐚 𝐚𝐦𝐞𝐫𝐢𝐜𝐚𝐧𝐚 𝐣𝐮𝐧𝐭𝐨 𝐚 𝐫𝐞𝐥𝐢𝐪𝐮𝐢𝐚𝐬 𝐝𝐞𝐥 𝐑𝐨𝐜𝐤 Twitter: @ElCapologist Twitch: https://www.twitch.tv/elcapologist Youtube: https://www.youtube.com/watch?v=br4bwIXvCjE&;;;;t=811s

In the latest episode of the NFL Fantasy Football Podcast, Marcas Grant, Michael F. Florio, and LaQuan Jones preview the two kickoff games on Thursday and Friday night with the Cowboys visiting the Eagles and the Chiefs facing the Chargers in Sao Paulo, Brazil. (02:14) Then, they discuss the biggest fantasy questions surrounding the rest of the Week 1 matchups. (7:02) Finally, each host shares their Must-Start of the Week (12:15) and Sleeper of the Week! (21:20) The NFL Fantasy Football Podcast is part of the NFL Podcast Network. NOTE: Time codes are approximate.See omnystudio.com/listener for privacy information.

Seven months after losing the Super Bowl, the Chiefs are back in action with the regular-season opener on Friday against the Los Angeles Chargers, in Sao Paulo, Brazil of all places. On SportsBeat KC, The Kansas City Star sports podcast, beat writer Pete Sweeney breaks down what to expect from a team bidding for its fourth straight Super Bowl appearance. First, we review the roster moves over the past week that helped shape this team. After a break, we look ahead at how standouts like Patrick Mahomes, Travis Kelce, Chris Jones and Isiah Pacheco will fare. Also, we submit our final record predictions. Learn more about your ad choices. Visit megaphone.fm/adchoices

En Brasil, el juicio contra el expresidente Jair Bolsonaro y varios de sus colaboradores más estrechos ha entrado hoy en su última fase con la Corte Suprema escuchando los alegatos finales de las partes. Hablamos con Amílcar Salas, politólogo de la Universidad de Sao Paulo.Escuchar audio

Notre correspondante au Brésil Sarah Cozzolino a suivi l'ouverture du procès de Jair Bolsonaro pour tentative de coup d'Etat. Elle nous en parle depuis Brasilia.  L'ouverture du procès fait aussi la Une de la presse brésilienne. « Le destin de Jair Bolsonaro bientôt sellé », titre Folha de Sao Paulo. Le site d'information de la chaine O Globo, G1, parle d'un procès inédit dans l'histoire du pays. Pour le journal Estadao, ce procès signifie « la fin de l'indulgence envers le putschisme qui a terni l'histoire républicaine du pays et affirme la force de la Constitution face à ses ennemis. » Le Washington Post partage cet avis : « C'est un tournant important, (…) dans un pays qui a traditionnellement privilégié la conciliation plutôt que les poursuites lorsqu'il s'agissait de crimes présumés contre l'État démocratique ». Et les représailles de Washington ne changent rien à la détermination des autorités brésiliennes de mener ce procès jusqu'au bout. « Le Brésil ne cédera pas à la pression », a déclaré le juge en charge du dossier, Alexandre de Moraes dans une interview au Washington Post : « Tout le monde ici reconnaît et respecte la puissance militaire et économique des États-Unis, mais le Brésil est indépendant et continuera de l'être. » À lire aussiBrésil: l'ex-président Jair Bolsonaro bientôt fixé sur son sort dans un procès historique Les sympathisants de l'ancien président gardent de l'espoir Ils tablent sur un possible acquittement ou une loi d'amnistie qui pourrait être voté par le Congrès. Selon le journal conservateur Gazeta do Povo, les partisans de l'ancien président se préparent à une grande manifestation nationale le 7 septembre prochain. En fait, la combinaison de la pression des États-Unis et de la population mobilisée dans les rues dimanche prochain nourrit l'espoir de l'opposition d'obtenir une suspension du procès ou l'acquittement de Jair Bolsonaro. Haïti : un nouveau directeur de la Police dans l'Artibonite Le 23 août dernier, Jacques Ader a été réinstallé à la tête de la Police nationale d'Haïti (PNH) dans le département de l'Artibonite. Déjà directeur de police dans cette région entre 2020 et 2021, il s'était distingué par la neutralisation d'Odma Louissaint, chef du gang « Base Grand Grif ». Son retour a été largement réclamé par la population lors de manifestations contre l'insécurité, qui le perçoit comme un « sauveur » capable de pacifier une zone désormais la plus affectée par la violence des gangs après Port-au-Prince. Mais pour mener à bien cette nouvelle mission, le nouveau directeur devra s'appuyer sur une justice pénale solide, d'après notre correspondant en Haïti, Ronel Paul. Le plus grand défi pour Jacques Ader : sécuriser la population tout en réorganisant et renforçant la coopération entre police et justice pour démanteler les gangs. Pérou, célèbre producteur de la « laine de dieux » Le Pérou, premier producteur mondial de laine d'alpaga, mise sur cette fibre douce, chaude, légère et thermorégulatrice pour se positionner sur le marché international, et pourquoi pas concurrencer le cachemire. Arequipa, au sud du pays, est le centre névralgique de cette production, avec des élevages situés à plus de 3 500 mètres d'altitude et de nombreuses boutiques locales. La majorité de la production péruvienne est exportée, surtout aux États-Unis, mais aussi en Chine et en Europe, avec un chiffre d'affaires de près de 200 millions de dollars en 2023. Pour répondre à cette demande, la plus grande usine d'alpaga du pays fonctionne 24 heures sur 24, combinant machines et contrôle manuel par 1 300 ouvriers. Le Pérou se concentre sur le marché premium et luxe, moins sensible aux tensions économiques, et développe des partenariats internationaux, comme avec une école de mode parisienne, pour valoriser le savoir-faire andin et ouvrir de nouvelles perspectives sur le marché européen. C'est un reportage réalisé par notre correspondant Martin Chabal. Journal de la 1ère En Martinique, le « R Prak » refait parler de lui. Le mouvement dirigé par Rodrigue Petitot a manifesté ce lundi devant les locaux de la SARA.

Brazil Declared War on Phone Theft — Should the UK Do the Same? The UK's battle against mobile phone theft is being hindered by a standoff between law enforcement and major handset manufacturers. Police want to use IMEI blocking to quickly disable stolen devices, but Apple and Google disagree on the approach. The deadlock raises questions about privacy, data access, and the most effective way to render stolen phones useless.  While the UK remains stuck in debate, Brazil's major players - from telecoms to government agencies - are working together to tackle phone theft head-on. Sao Paulo-based tech company Qintess has developed a multi-layered system: detecting cloned devices through call pattern analysis, a secure app that lets users remotely lock stolen phones, and a restricted IMEI list that instantly renders devices unusable. The result is a coordinated, nationwide shield against phone crime.   The programme is presented by Gareth Mitchell and the studio expert Ania Lichtarowicz   More on this week's stories: Safe Cell Phone App Qintess Apple and Google clash with Police over mobile phone theft Production Manager: Liz Tuohy Editor: Ania Lichtarowicz For the PodExtra version of the show please subscribe via this link: https://somewhere-on-earth-the-global-tech-podcast-the-podextra-edition.pod.fan/ Follow us on the socials: Join our Facebook group Instagram BlueSky   If you like Somewhere on Earth, please rate and review it on Apple Podcasts or Spotify   Contact us by email: hello@somewhereonearth.co Send us a voice note: via WhatsApp: +44 7486 329 484   Find a Story + Make it News = Change the World Learn more about your ad choices. Visit megaphone.fm/adchoices

On this edition of Cougar Tracks, KSL Sports BYU Insider Mitch Harper caught up with BYU football head coach Kalani Sitake to preview the 2025 season. Sitake discussed the decision to start true freshman Bear Bachmeier in the season opener against Portland State. The 10th-year head coach also noted how Bachmeier has been able to learn the playbook so quickly. Also, Harper shares his practice observation notes from the final day of fall camp practices. Players that caught his attention. Along with true freshman QB Emerson Geilman, who shared his mission call to Sao Paulo, Brazil, with the team. Then, finally, Aaron Roderick shared that BYU football is going to remain aggressive in its play calling style with a true freshman as the QB1. Subscribe to the Cougar Tracks Podcast so you don't miss any of the daily episodes. Cougar Tracks is on YouTube and X every weekday at Noon (MT), and KSL NewsRadio at 6:30 p.m. (MT). Apple: https://podcasts.apple.com/us/podcast/cougar-tracks/id1146971609 YouTube Podcast: https://kslsports.com/category/podcast_results/?sid=2035&n=Cougar%20Tracks Download the KSL Sports app Google: https://play.google.com/store/apps/details?id=com.bonneville.kslsports&hl=en_US  iOS: https://apps.apple.com/us/app/ksl-sports/id143593

Alors que Trump a suspendu les visas pour les étudiants étrangers, « La Story », le podcast d'actualité des « Echos », fait une série sur ces écoles des pays émergents qui forment leurs élites et à qui cette politique pourrait profiter. Pour ce deuxième épisode, Margaux Boulte et son invité Thierry Ogier nous font découvrir l'université de Sao Paulo (USP) par où sont passés une douzaine des présidents brésiliens.Retrouvez l'essentiel de l'actualité économique grâce à notre offre d'abonnement Access : abonnement.lesechos.fr/lastoryLa Story est un podcast des « Echos » présenté par Margaux Boulte. Cet épisode a été enregistré en juillet 2025. Rédaction en chef : Clémence Lemaistre. Invité : Thierry Ogier (correspondant des « Echos » au Brésil). Réalisation : Nicolas Jean. Chargée de production et d'édition : Michèle Warnet. Musique : Théo Boulenger. Identité graphique : Upian. Photo : Chine Nouvelle/SIPA. Sons : TV5 Monde, France 5, Euronews, Faculdade de Direito da USP. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

This week Host Graihagh Jackson grabs a chat with the BBC's correspondents in two countries that will shape our future climate. Brazil is about to host the giant COP climate conference in the Amazon, but the pace of reducing deforestation has just slowed and there are concerns about potentially weaker environmental standards. Ione Wells in Sao Paulo also talks Graihagh through proposals for oil exploration in the mouth of the rainforest. Plus, China has just started work on the world's biggest hydroelectric dam. It's a huge 167-billion dollar project to bring power from Tibet to Hong Kong. The dam will increase Beijing's use of renewable energy, but comes with a potential environmental cost, as well as the risk of creating tension with China's neighbours. Laura Bicker gives us some staggering facts and figures about the dam – as well as an explanation of how fish can use “ladders”. Got a climate question you'd like answered? Email: TheClimateQuestion@BBC.com or WhatsApp: +44 8000 321 721Presenter: Graihagh Jackson with Jordan Dunbar Producer: Diane Richardson Production Co-Ordinator: Rosie Strawbridge Sound Engineers: Dafydd Evans and Tom Brignell Editor: Simon Watts

Hernán Peláez y Martín de Francisco analizan la actuación de Cardona en el partido de ida de los octavos de final de la Copa Libertadores.

Carlos Antonio Vélez, en sus Palabras Mayores del 13 de agosto de 2025, habló de Luis Díaz en Bayern Múnich, también analizó lo hecho por Atlético Nacional frente a Sao Paulo en Copa Libertadores y de la actuación de América de Cali y Once Caldas en la Copa Sudamericana.

跟大家分享飛30個小時有多痛苦↓↓↓ (03:00) 為什麼選擇巴西 (18:10) NBA開幕戰 (22:30) 推歌時間～ Larry June ft. Don Toliver - 100 Bags 別忘了小額贊助

Carlos Antonio Vélez, en sus Palabras Mayores del 12 de agosto de 2025, habló de los partidos de Atlético Nacional frente a Sao Paulo en Copa Libertadores y de América contra Fluminense y Once Caldas ante Huracán en Copa Sudamericana. También se refirió al presente de James en México y a la Selección Colombia.

Este episodio forma parte de una selección para el verano de EL PAÍS Audio. Este episodio se emitió el 21 de octubre de 2024 Cada día, cuatro brasileñas mueren por feminicidio. Lo sabemos por la estadística porque lo cierto es que no hay un recuento oficial que precise quiénes son. Pero, en Cruzeiro, una pequeña ciudad en el estado brasileño de Sao Paulo, vive Regina Jardim, una profesora jubilada que ha creado en Internet un memorial de mujeres asesinadas por su parejas o ex parejas. Ha recopilado ya más de 20.000 y es el único recuento exhaustivo de víctimas de feminicidio que hay en un país donde los organismos oficiales solo ofrecen estimaciones. Créditos: Realizan: Naiara Galarraga Gortázar y Jimena Marcos Presenta y dirige: Silvia Cruz Lapeña Edición: Ana Ribera Diseño de sonido: Nicolás Tsabertidis Sintonía: Jorge Magaz Si tienes quejas, dudas o sugerencias, escribe a defensora@elpais.es o manda un audio a +34 649362138 (no atiende llamadas).

Note aux auditrices et auditeurs : cet épisode a été diffusé une première fois le 25 septembre.Pour cet épisode, on a beaucoup hésité sur le titre. On a envisagé "Manu Chao ha vuelto" : Manu Chao est de retour.Et aussi "Manu Chao, troisième génération", parce qu'aujourd'hui, l'artiste franco-espagnol à l'énergie contagieuse a conquis une troisième fournée de fans : des petits enfants des adeptes de son premier groupe, la Mano Negra, qui fredonnent Clandestino, comme Jacques, 18 ans, croisé à Paris. Le chanteur Manu Chao est de retour avec Viva Tu, vive toi, un album en 13 titres sorti le 20 septembre, le premier depuis 2007.Mais en réalité, il n'était jamais vraiment parti, il était juste en tournée permanente sur les routes du monde. Il n'a jamais cessé de composer, de sortir des titres, de lancer de nouveaux projets, et de soutenir des nouvelles causes. Son dernier album est encore une invitation au voyage, de Barcelone, à Sao Paulo, en passant par Athènes et la porte des Lilas à Paris. Manu Chao, se faufile partout. Des favelas de Rio aux camps de réfugiés en Grèce, mais qui est-il ? Sur le fil a posé la question à Fanny Lattach, de la rubrique musique à l'AFP, à Gaston, dessinateur qui vient de lui consacrer une BD, et au journaliste britannique Peter Culshaw, qui l'a suivi pendant cinq ans. Enregistrements sur le terrain : Fanny Lattach et Michaëla Cancela-KiefferRéalisation : Michaëla Cancela-KiefferUn grand merci au label Because Music qui a autorisé la diffusion d'extraits de chansons de Manu Chao, dans l'ordre:Clandestino (1998), Viva Tu (Album Viva Tu, 2024), Me gustas tu (Album Próxima Estación Esperanza, 2001), Motoboys, Tu te vas et Tantas tierras (Album Viva Tu, 2024)Pour aller plus loin :De la Mano à Manu Chao, par GastonClandestino, à la recherche de Manu Chao, par Peter CulshawSur le Fil est le podcast quotidien de l'AFP. Vous avez des commentaires ? Ecrivez-nous à podcast@afp.com. Si vous aimez, abonnez-vous, parlez de nous autour de vous et laissez-nous plein d'étoiles sur votre plateforme de podcasts préférée pour mieux faire connaître notre programme.Ce podcast fait l'objet d'une clause de opt-out:Sous réserve des dispositions de l'article L.122-5-3.II. du code de la propriété intellectuelle, tout accès à ou utilisation (tels que, à titre non exhaustif, la reproduction, l'agrégation et l'archivage) du contenu de ce podcast et de sa description, pour toute activité systématique ou automatisée liée à la récupération, la fouille, l'extraction, l'agrégation, l'analyse, l'exploration ou la collecte de textes, d'extraits sonores, et/ou de données, par l'intermédiaire de tout "robot", "bot", "spider", "scraper", ou de tout autre dispositif, programme, technique, outil, procédé ou méthode, réalisé dans le but de créer, développer, entraîner, tester, évaluer, modifier et/ou permettre l'exécution de logiciels, algorithmes et modèles d'apprentissage automatique/d'intelligence artificielle ou à une quelconque autre fin, sans l'autorisation préalable écrite de l'AFP, est strictement interdit. La présente disposition des CG vaut opposition expresse de l'AFP au sens des articles L. 122-5-3.III. et R. 122-28 du Code de la propriété intellectuelle. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Analiza junto a Salomé y David las cuotas de algunos partidosde los playoffs de #Champions, los encuentros de los equiposcolombianos en #CopaLibertadores y #CopaSudamericana, yacompáñalos en el armado de la apuesta del partidazo de lafecha entre #Nacional vs #SaoPaulo.

On this week's Double Stint, Jonathan Grace and John Dagys recap the FIA World Endurance Championship and IMSA WeatherTech SportsCar Championship action in Sao Paulo and Canadian Tire Motorsport Park, before catching up on the latest headlines, answer a listener question and more.

Thousands on the streets of Brazil, Sao Paulo's Paulista Avenue packed, angry and protesting US President Donald Trump and his imposition of 50% tariffs on Brazilian products. Trump's new tariffs on Brazil are in response to the country's trial against Trump ally, former far-right Brazilian President Jair Bolsonaro. Bolsonaro is accused of leading a “criminal organization” that looked to stop his successor Luiz Inacio Lula da Silva from assuming the presidency after he won the 2022 elections. The Brazilian courts will decide. Trump has other plans. But Brazilian leaders say they won't back down. “If there's one thing a government cannot tolerate, it's interference by one country in the sovereignty of another,” said Brazilian President Lula. “And even more seriously, interference by a president of another country in the Brazilian justice system.”This is episode 57 of Stories of Resistance—a podcast co-produced by The Real News and Global Exchange. Independent investigative journalism, supported by Global Exchange's Human Rights in Action program. Each week, we'll bring you stories of resistance like this. Inspiration for dark times.If you like what you hear, please subscribe, like, share, comment, or leave a review. Sign up for the Stories of Resistance podcast feed, either in Spotify, Apple Podcasts, Spreaker, or wherever you listen.Please consider supporting this podcast and Michael Fox's reporting on his Patreon account: patreon.com/mfox. There you can also see exclusive pictures, video, and interviews. Written and produced by Michael Fox.Resources: Brazil on Fire podcastEpisode: An autopsy of Bolsonaro's failed coupSubscribe to Stories of Resistance podcast hereBecome a member and join the Stories of Resistance Supporters Club today!Sign up for our newsletterFollow us on BlueskyLike us on FacebookFollow us on TwitterDonate to support this podcast